SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 52 filers reported holding SCPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,767 | -91.3% | 18,647 | -87.6% | 0.02% | -93.4% |
Q2 2023 | $1,528,500 | -51.1% | 150,000 | -68.7% | 0.24% | -61.0% |
Q3 2022 | $3,126,000 | -26.6% | 479,383 | -45.8% | 0.62% | -19.8% |
Q2 2022 | $4,261,000 | -22.7% | 884,008 | -8.9% | 0.78% | +7.2% |
Q1 2022 | $5,510,000 | +21.8% | 970,098 | +7.6% | 0.72% | +7.6% |
Q4 2021 | $4,525,000 | -24.5% | 901,362 | 0.0% | 0.67% | +59.7% |
Q3 2021 | $5,994,000 | -10.4% | 901,362 | -17.7% | 0.42% | -22.0% |
Q2 2021 | $6,690,000 | -23.1% | 1,095,024 | -16.3% | 0.54% | +84.6% |
Q1 2021 | $8,703,000 | +12.2% | 1,308,699 | -10.7% | 0.29% | -14.3% |
Q4 2020 | $7,756,000 | -29.7% | 1,466,147 | -1.0% | 0.34% | -57.1% |
Q3 2020 | $11,033,000 | +2.1% | 1,481,147 | +0.9% | 0.80% | -7.2% |
Q2 2020 | $10,809,000 | +36.0% | 1,468,647 | +36.8% | 0.86% | +44.1% |
Q1 2020 | $7,945,000 | – | 1,073,647 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |